It is timely, because it undoubtedly exposes Ogilvy's shortcomings in safety control. More ironically, Ogilvy & Mather in Jingmen has launched a series of safety month activities, which can well explain the curiosity of the outside world. This major event involving human life has obviously happened for some time. Why was Ogilvy's announcement not released in time until it was reported by the media yesterday? After so many days of such a big accident, with the gradual fermentation of public opinion, there are more and more questions about whether Ogilvy intends to hide major events.

Ogilvy Medical admitted that some employees of Ogilvy Medical Products Co., Ltd., a subsidiary of the company, developed symptoms of physical discomfort and were diagnosed as poisoning. The hospital * * * detected 43 abnormal indicators, and 1 employee died of acute myocardial infarction during treatment. 2 1 Century Business Herald reporter also learned from a local person in Jingmen that according to his understanding, some employees of Ogilvy & Mather in Jingmen were sent to the First People's Hospital of Jingmen for treatment. Ogilvy & Mather once fell more than 5%, down 2. 10% to 12.60 yuan.

Ogilvy said that 36 people are being treated in three hospitals in Wuhan. Three seriously ill colleagues have been transferred to tongji hospital Union Medical College Hospital for treatment. Three colleagues are seriously ill, while others are in stable condition. 10 colleagues' liver function indexes have returned to normal, and they are waiting for experts to evaluate whether they can leave the hospital. All treatment-related expenses are borne by the company, including the logistical support of family members, and the company will also bear the expenses.

We should know that Ogilvy Medical has realized the integrated production of the whole industrial chain from spinning, weaving, decoloring, processing, packaging, sterilization and testing. With stable quality, timely batch supply and diverse procurement requirements, it is a leading manufacturer of medical dressings in China. Under such conditions, the global epidemic prevention and control has entered a normal stage, and the price and quantity of infection protection products have returned to normal levels. In addition to related products, the company's other businesses continued to develop healthily.